disulfiram has been researched along with Thyroid Carcinoma, Anaplastic in 1 studies
Thyroid Carcinoma, Anaplastic: An aggressive THYROID GLAND malignancy which generally occurs in IODINE-deficient areas in people with previous thyroid pathology such as GOITER. It is associated with CELL DEDIFFERENTIATION of THYROID CARCINOMA (e.g., FOLLICULAR THYROID CARCINOMA; PAPILLARY THYROID CANCER). Typical initial presentation is a rapidly growing neck mass which upon metastasis is associated with DYSPHAGIA; NECK PAIN; bone pain; DYSPNEA; and NEUROLOGIC DEFICITS.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Shimamura, M | 1 |
| Kurashige, T | 1 |
| Mitsutake, N | 1 |
| Nagayama, Y | 1 |
1 other study available for disulfiram and Thyroid Carcinoma, Anaplastic
| Article | Year |
|---|---|
Aldehyde dehydrogenase activity plays no functional role in stem cell-like properties in anaplastic thyroid cancer cell lines.
Topics: Cell Line, Tumor; Cell Survival; Disulfiram; Humans; Neoplastic Stem Cells; p-Aminoazobenzene; Thyro | 2017 |